Loading clinical trials...
Loading clinical trials...
Impact of the Use of C-reactive Protein in a Micro-method on the Prescription of Antibiotics in General Practitioners Consulting in the Office
Respiratory infections, including episodes of coughing with fever, are the main cause of outpatient antibiotic prescription, while a minority of them are linked to bacterial infections requiring antibiotic. These prescriptions are often performed by general practitioners. These unnecessary antibiotic contribute to increased bacterial resistance, side effects and unnecessary costs. Campaigns for the correct prescription of antibiotics have had a real but partial or transient success. C-reactive protein micro-method (POCT-CRP) could help to differentiate between viral and bacterial infections and thus contribute to the proper use of antibiotics. The decrease in prescription of antibiotics is likely to have an even stronger positive impact in countries like France, where prescription is high. The objective of this study is to evaluate the use of POCT-CRP in the general practitioner's office in case of suspected respiratory infection.
Age
3 - No limit years
Sex
ALL
Healthy Volunteers
No
22 rue de Silly
Boulogne, France
18 rue Sainte Bathilde
Chelles, France
25 avenue des frères Lumière
Cormeilles-en-Parisis, France
8 Rue Saint-Exupéry
Meudon-la-Forêt, France
258 Bis Rue de Paris
Montreuil, France
61bis Boulevard de Charonne
Paris, France
25 Rue de Fécamp
Paris, France
237 Rue de la Croix Nivert,
Paris, France
1 Rue Colette Magny
Paris, France
391 Rue des Pyrénées
Paris, France
Start Date
May 1, 2018
Primary Completion Date
March 13, 2023
Completion Date
March 13, 2023
Last Updated
August 7, 2023
406
ACTUAL participants
Care with C-reactive protein assay in micro method
DIAGNOSTIC_TEST
Lead Sponsor
Centre Hospitalier Intercommunal Creteil
Collaborators
NCT07396428
NCT07278700
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions